News
Lindblad Expeditions Holdings, Inc. ( NASDAQ: LIND) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Rick Goldberg - Chief Financial Officer Natalya Leahy - Chief Executive Officer ...
Seeking Alpha on MSN29m
Esperion outlines Q2 prescription growth, targets triple combo launch by 2027Discover Esperion Therapeutics' Q1 2025 highlights: 63% revenue growth, market expansion, and innovative LDL-lowering therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback